WASP plays a novel role in regulating platelet responses dependent on αiIbβ3 integrin outside-in signalling

British Journal of Haematology

Volumn 148, Issue 3, 2010, Pages 416-427

  Shcherbina, Anna ^a,b   Cooley, Jessica ^a   Lutskiy, Maxim I ^a   Benarafa, Charaf ^a   Gilbert, Gary E ^c   Remold O'Donnell, Eileen ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b Institute of Paediatric Haematology   (Russian Federation)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Fibrin clot retraction; Integrins; Phosphatidylserine exposure; Platelet disorder; Wiskott Aldrich syndrome

Indexed keywords

ALPHA2B BETA3 INTEGRIN; DUAL SPECIFICITY PHOSPHATASE 2; FIBRINOGEN; INTEGRIN; PHOSPHATIDYLSERINE; UNCLASSIFIED DRUG; WISKOTT ALDRICH SYNDROME PROTEIN;

ACTIN FILAMENT; ADOLESCENT; ADULT; ARTICLE; BLEEDING; BLOOD CLOTTING; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOSKELETON; ENZYME BINDING; FIBRIN CLOT; FIBRINOLYSIS; GENE MUTATION; HUMAN; INFANT; LAMELLIPODIUM; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEFICIENCY; PROTEIN FUNCTION; PROTEIN IMMOBILIZATION; PROTEIN LOCALIZATION; REGULATORY MECHANISM; SCHOOL CHILD; SIGNAL TRANSDUCTION; THROMBOCYTE; THROMBOCYTE FUNCTION;

ADOLESCENT; ADULT; ANIMALS; BLOOD PLATELETS; CHILD; CHILD, PRESCHOOL; FEMALE; FIBRIN; FIBRINOGEN; HEMOSTASIS; HUMANS; INFANT; MALE; MICE; MICE, KNOCKOUT; MIDDLE AGED; PLATELET AGGREGATION; PLATELET COUNT; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; SIGNAL TRANSDUCTION; WISKOTT-ALDRICH SYNDROME; WISKOTT-ALDRICH SYNDROME PROTEIN; YOUNG ADULT;

EID: 74049133295     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2009.07959.x     Document Type: Article

References (46)

1. Arias-Salgado, E.G., Lizano, S., Sarkar, S., Brugge, J.S., Ginsberg, M.H. Shattil, S.J. (2003) Src kinase activation by direct interaction with the integrin beta cytoplasmic domain. Proceedings of the National Academy of Sciences of the United States of America, 100, 13298 13302.
2. Baldini, M.G. (1972) Nature of the platelet defect in the Wiskott-Aldrich syndrome. Annals of the New York Academy of Sciences, 201, 437 444.
3. Bevers, E.M., Comfurius, P., van Rijn, J.L., Hemker, H.C. Zwaal, R.F. (1982) Generation of prothrombin-converting activity and the exposure of phosphatidylserine at the outer surface of platelets. European Journal of Biochemistry, 122, 429 436.
4. Cauwenberghs, S., Feijge, M.A., Harper, A.G., Sage, S.O., Curvers, J. Heemskerk, J.W. (2006) Shedding of procoagulant microparticles from unstimulated platelets by integrin-mediated destabilization of actin cytoskeleton. FEBS Letters, 580, 5313 5320.
5. Coller, B.S. Shattil, S.J. (2008) The GPIIb/IIIa (integrin alphaIIbbeta3) odyssey: a technology-driven saga of a receptor with twists, turns, and even a bend. Blood, 112, 3011 3025.
6. Corash, L., Shafer, B. Blaese, R.M. (1985) Platelet-associated immunoglobulin, platelet size, and the effect of splenectomy in the Wiskott-Aldrich syndrome. Blood, 65, 1439 1443.
7. Falet, H., Hoffmeister, K.M., Neujahr, R. Hartwig, J.H. (2002) Normal Arp2/3 complex activation in platelets lacking WASp. Blood, 100, 2113 2122.
8. Faruqi, T.R., Weiss, E.J., Shapiro, M.J., Huang, W. Coughlin, S.R. (2000) Structure-function analysis of protease-activated receptor 4 tethered ligand peptides. Determinants of specificity and utility in assays of receptor function. Journal of Biological Chemistry, 275, 19728 19734.
9. Flaumenhaft, R. (2006) Formation and fate of platelet microparticles. Blood Cells, Molecules, and Diseases, 36, 182 187.
10. Fox, J.E. (1993) The platelet cytoskeleton. Thrombosis and Haemostasis, 70, 884 893.
11. Fox, J.E., Austin, C.D., Boyles, J.K. Steffen, P.K. (1990) Role of the membrane skeleton in preventing the shedding of procoagulant-rich microvesicles from the platelet plasma membrane. Journal of Cell Biology, 111, 483 493.
12. Gemmell, C.H., Sefton, M.V. Yeo, E.L. (1993) Platelet-derived microparticle formation involves glycoprotein IIb-IIIa. Inhibition by RGDS and a Glanzmann's thrombasthenia defect. Journal of Biological Chemistry, 268, 14586 14589.
13. Goodman, S.L. (1999) Sheep, pig, and human platelet-material interactions with model cardiovascular biomaterials. Journal of Biomedical Materials Research, 45, 240 250.
14. Gross, B.S., Wilde, J.I., Quek, L., Chapel, H., Nelson, D.L. Watson, S.P. (1999) Regulation and function of WASp in platelets by the collagen receptor, glycoprotein VI. Blood, 94, 4166 4176.
15. Grottum, K.A., Hovig, T., Holmsen, H., Abrahamsen, A.F., Jeremic, M. Seip, M. (1969) Wiskott-Aldrich syndrome: qualitative platelet defects and short platelet survival. British Journal of Haematology, 17, 373 388.
16. Hartwig, J.H. DeSisto, M. (1991) The cytoskeleton of the resting human blood platelet: structure of the membrane skeleton and its attachment to actin filaments. Journal of Cell Biology, 112, 407 425.
17. Heemskerk, J.W., Bevers, E.M. Lindhout, T. (2002) Platelet activation and blood coagulation. Thrombosis and Haemostasis, 88, 186 193.
18. Higgs, H.N. Pollard, T.D. (2000) Activation by Cdc42 and PIP(2) of Wiskott-Aldrich syndrome protein (WASp) stimulates actin nucleation by Arp2/3 complex. Journal of Cell Biology, 150, 1311 1320.
19. Jenkins, A.L., Nannizzi-Alaimo, L., Silver, D., Sellers, J.R., Ginsberg, M.H., Law, D.A. Phillips, D.R. (1998) Tyrosine phosphorylation of the beta3 cytoplasmic domain mediates integrin-cytoskeletal interactions. Journal of Biological Chemistry, 273, 13878 13885.
20. Kenney, D. (1990) Wiskott-Aldrich syndrome and related X-linked thrombocytopenia. Current Opinion in Pediatrics, 2, 932 935.
21. Kim, A.S., Kakalis, L.T., Abdul-Manan, N., Liu, G.A. Rosen, M.K. (2000) Autoinhibition and activation mechanisms of the Wiskott-Aldrich syndrome protein. Nature, 404, 151 158.
22. Kulkarni, S., Woollard, K.J., Thomas, S., Oxley, D. Jackson, S.P. (2007) Conversion of platelets from a proaggregatory to a proinflammatory adhesive phenotype: role of PAF in spatially regulating neutrophil adhesion and spreading. Blood, 110, 1879 1886.
23. Law, D.A., DeGuzman, F.R., Heiser, P., Ministri-Madrid, K., Killeen, N. Phillips, D.R. (1999) Integrin cytoplasmic tyrosine motif is required for outside-in alphaIIbbeta3 signalling and platelet function. Nature, 401, 808 811.
24. Lutskiy, M.I., Shcherbina, A., Bachli, E.T., Cooley, J. Remold-O'Donnell, E. (2007) WASP localizes to the membrane skeleton of platelets. British Journal of Haematology, 139, 98 105.
25. Murphy, S., Oski, F.A. Gardner, F.H. (1969) Hereditary thrombocytopenia with an intrinsic platelet defect. New England Journal of Medicine, 281, 857 862.
26. Obergfell, A., Eto, K., Mocsai, A., Buensuceso, C., Moores, S.L., Brugge, J.S., Lowell, C.A. Shattil, S.J. (2002) Coordinate interactions of Csk, Src, and Syk kinases with [alpha]IIb[beta]3 initiate integrin signaling to the cytoskeleton. Journal of Cell Biology, 157, 265 275.
27. Ochs, H.D., Slichter, S.J., Harker, L.A., Von Behrens, W.E., Clark, R.A. Wedgwood, R.J. (1980) The Wiskott-Aldrich syndrome: studies of lymphocytes, granulocytes, and platelets. Blood, 55, 243 252.
28. Oda, A. Ochs, H.D. (2000) Wiskott-Aldrich syndrome protein and platelets. Immunological Reviews, 178, 111 117.
29. Osdoit, S. Rosa, J.P. (2001) Fibrin clot retraction by human platelets correlates with alpha(IIb)beta(3) integrin-dependent protein tyrosine dephosphorylation. Journal of Biological Chemistry, 276, 6703 6710.
30. Prislovsky, A., Marathe, B., Hosni, A., Bolen, A.L., Nimmerjahn, F., Jackson, C.W., Weiman, D. Strom, T.S. (2008) Rapid platelet turnover in WASP(-) mice correlates with increased ex vivo phagocytosis of opsonized WASP(-) platelets. Experimental Hematology, 36, 609 623.
31. Racanelli, A.L., Gibbs, S.K., Zondlo, S.C., Seiffert, D.A., Friedman, S.M. Feuerstein, G.Z. (2003) Differential effect of the GPIIb/IIIa antagonist orbofiban on human platelet aggregate formation in vitro. Thrombosis Research, 110, 99 105.
32. Rengan, R. Ochs, H.D. (2000) Molecular biology of the Wiskott-Aldrich syndrome. Reviews in Immunogenetics, 2, 243 255.
33. Reverter, J.C., Beguin, S., Kessels, H., Kumar, R., Hemker, H.C. Coller, B.S. (1996) Inhibition of platelet-mediated, tissue factor-induced thrombin generation by the mouse/human chimeric 7E3 antibody. Potential implications for the effect of c7E3 Fab treatment on acute thrombosis and "clinical restenosis". Journal of Clinical Investigation, 98, 863 874.
34. Sabri, S., Foudi, A., Boukour, S., Franc, B., Charrier, S., Jandrot-Perrus, M., Farndale, R.W., Jalil, A., Blundell, M.P., Cramer, E.M., Louache, F., Debili, N., Thrasher, A.J. Vainchenker, W. (2006) Deficiency in the Wiskott-Aldrich protein induces premature proplatelet formation and platelet production in the bone marrow compartment. Blood, 108, 134 140.
35. Savage, B. Ruggeri, Z.M. (1991) Selective recognition of adhesive sites in surface-bound fibrinogen by glycoprotein IIb-IIIa on nonactivated platelets. Journal of Biological Chemistry, 266, 11227 11233.
36. Schoenwaelder, S.M., Yuan, Y., Cooray, P., Salem, H.H. Jackson, S.P. (1997) Calpain cleavage of focal adhesion proteins regulates the cytoskeletal attachment of integrin alphaIIbbeta3 (platelet glycoprotein IIb/IIIa) and the cellular retraction of fibrin clots. Journal of Biological Chemistry, 272, 1694 1702.
37. Shcherbina, A., Rosen, F.S. Remold-O'Donnell, E. (1999) Pathological events in platelets of Wiskott-Aldrich syndrome patients. British Journal of Haematology, 106, 875 883.
38. Shi, J., Pipe, S.W., Rasmussen, J.T., Heegaard, C.W. Gilbert, G.E. (2008) Lactadherin blocks thrombosis and hemostasis in vivo: correlation with platelet phosphatidylserine exposure. Journal of Thrombosis and Haemostasis, 6, 1167 1174.
39. Snapper, S.B., Rosen, F.S., Mizoguchi, E., Cohen, P., Khan, W., Liu, C.H., Hagemann, T.L., Kwan, S.P., Ferrini, R., Davidson, L., Bhan, A.K. Alt, F.W. (1998) Wiskott-Aldrich syndrome protein-deficient mice reveal a role for WASP in T but not B cell activation. Immunity, 9, 81 91.
40. Soriani, A., Moran, B., de Virgilio, M., Kawakami, T., Altman, A., Lowell, C., Eto, K. Shattil, S.J. (2006) A role for PKCtheta in outside-in alpha(IIb)beta3 signaling. Journal of Thrombosis and Haemostasis, 4, 648 655.
41. Strom, T.S. (2009) The thrombocytopenia of WAS: a familial form of ITP? Immunologic Research, 44, 42 53.
42. Strom, T.S., Li, X., Cunningham, J.M. Nienhuis, A.W. (2002) Correction of the murine Wiskott-Aldrich syndrome phenotype by hematopoietic stem cell transplantation. Blood, 99, 4626 4628.
43. Sullivan, K.E., Mullen, C.A., Blaese, R.M. Winkelstein, J.A. (1994) A multiinstitutional survey of the Wiskott-Aldrich syndrome. Journal of Pediatrics, 125, 876 885.
44. Tsuboi, S., Nonoyama, S. Ochs, H.D. (2006) Wiskott-Aldrich syndrome protein is involved in alphaIIb beta3-mediated cell adhesion. EMBO Reports, 7, 506 511.
45. Vu, T.K., Hung, D.T., Wheaton, V.I. Coughlin, S.R. (1991) Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell, 64, 1057 1068.
46. Zhang, J., Shehabeldin, A., da Cruz, L.A., Butler, J., Somani, A.K., McGavin, M., Kozieradzki, I., dos Santos, A.O., Nagy, A., Grinstein, S., Penninger, J.M. Siminovitch, K.A. (1999) Antigen receptor-induced activation and cytoskeletal rearrangement are impaired in Wiskott-Aldrich syndrome protein-deficient lymphocytes. Journal of Experimental Medicine, 190, 1329 1342.